- Home
- CXDO vs IKT Comparison
CXDO vs IKT Comparison
Compare CXDO & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXDO
- IKT
- Stock Information
- Founded
- CXDO 1995
- IKT 2008
- Country
- CXDO United States
- IKT United States
- Employees
- CXDO N/A
- IKT N/A
- Industry
- CXDO Telecommunications Equipment
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- CXDO Telecommunications
- IKT Health Care
- Exchange
- CXDO Nasdaq
- IKT Nasdaq
- Market Cap
- CXDO 194.0M
- IKT 167.2M
- IPO Year
- CXDO 1998
- IKT 2020
- Fundamental
- Price
- CXDO $6.45
- IKT $2.16
- Analyst Decision
- CXDO Strong Buy
- IKT Buy
- Analyst Count
- CXDO 2
- IKT 2
- Target Price
- CXDO $8.75
- IKT $8.00
- AVG Volume (30 Days)
- CXDO 251.5K
- IKT 168.5K
- Earning Date
- CXDO 03-04-2025
- IKT 03-26-2025
- Dividend Yield
- CXDO N/A
- IKT N/A
- EPS Growth
- CXDO N/A
- IKT N/A
- EPS
- CXDO 0.06
- IKT N/A
- Revenue
- CXDO $60,838,000.00
- IKT $1.00
- Revenue This Year
- CXDO $12.19
- IKT N/A
- Revenue Next Year
- CXDO $12.65
- IKT N/A
- P/E Ratio
- CXDO $98.50
- IKT N/A
- Revenue Growth
- CXDO 14.36
- IKT N/A
- 52 Week Low
- CXDO $2.92
- IKT $1.12
- 52 Week High
- CXDO $7.34
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- CXDO 52.18
- IKT 46.75
- Support Level
- CXDO $5.73
- IKT $1.91
- Resistance Level
- CXDO $7.34
- IKT $2.22
- Average True Range (ATR)
- CXDO 0.54
- IKT 0.24
- MACD
- CXDO -0.06
- IKT -0.00
- Stochastic Oscillator
- CXDO 45.60
- IKT 35.71
About CXDO Crexendo Inc.
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of revenue from the Cloud telecommunications segment.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.